Cargando…
Outcomes of treatment with sirolimus for non-infectious uveitis: a meta-analysis and systematic review
BACKGROUND: Uveitis is a group of intraocular inflammatory diseases whose primary treatment involves immunosuppression. Although corticosteroids (CSs) remain the mainstay therapy, sirolimus is among the recently studied immunomodulatory drugs for treating noninfectious uveitis (NIU). OBJECTIVE: The...
Autores principales: | Cabahug, Vicente Lorenzo O, Uy, Harvey S, Yu-Keh, Ellen, Sapno, Kristine Joy D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478489/ https://www.ncbi.nlm.nih.gov/pubmed/31114144 http://dx.doi.org/10.2147/OPTH.S198401 |
Ejemplares similares
-
Clinical outcomes of a beveled tip, ultra-high speed, 25-gauge pars plana vitrectomy system
por: Uy, Harvey S., et al.
Publicado: (2022) -
Assessment of changes in quality of life among patients in the SAVE Study - Sirolimus as therapeutic Approach to uVEitis: a randomized study to assess the safety and bioactivity of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis
por: Vigil, Erin M, et al.
Publicado: (2015) -
Ocular tolerability and efficacy of intravitreal and subconjunctival injections of sirolimus in patients with non-infectious uveitis: primary 6-month results of the SAVE Study
por: Nguyen, Quan Dong, et al.
Publicado: (2013) -
Outcome of adalimumab monotherapy in paediatric non-infectious uveitis
por: Al-Julandani, DA, et al.
Publicado: (2023) -
Effect of vitreomacular adhesion on the treatment outcomes in the STOP-Uveitis clinical trial for non-infectious uveitis
por: Hassan, Muhammad, et al.
Publicado: (2019)